title: It all starts at the ends: multifaceted involvement of C- and N-terminally modified cholinesterases in Alzheimer's disease.
abstract: In Alzheimer's disease (AD), premature demise of acetylcholine-producing neurons and the consequent decline of cholinergic transmission associate with the prominent cognitive impairments of affected individuals. However, the enzymatic activities of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are altered rather late in the disease progress. This raised questions regarding the causal involvement of AChE and BChE in AD. Importantly, single nucleotide polymorphisms (SNPs), alternative splicing, and alternate promoter usage generate complex expression of combinatorial cholinesterase (ChE) variants, which called for testing the roles of specific variants in AD pathogenesis. We found accelerated amyloid fibril formation in engineered mice with enforced over-expression of the AChE-S splice variant which includes a helical C-terminus. In contrast, the AChE-R variant, which includes a naturally unfolded C-terminus, attenuated the oligomerization of amyloid fibrils and reduced amyloid plaque formation and toxicity. An extended N-terminus generated by an upstream promoter enhanced the damage caused by N-AChE-S, which in cell cultures induced caspases and GSK3 activation, tau hyperphosphorylation, and apoptosis. In the post-mortem AD brain, we found reduced levels of the neuroprotective AChE-R and increased levels of the neurotoxic N-AChE-S, suggesting bimodal contribution to AD progress. Finally, local unwinding of the α-helical C-terminal BChE peptide and loss of function of the pivotal tryptophan at its position 541 impair amyloid fibril attenuation by the common BChE-K variant carrying the A539T substitution, in vitro. Together, our results point to causal yet diverse involvement of the different ChEs in the early stages of AD pathogenesis. Harnessing the neuroprotective variants while reducing the levels of damaging ones may hence underlie the development of novel therapeutics.
authors.affiliation: Department of Biological Chemistry and the Edmond and Lily Safra Center of Neuroscience, The Hebrew University of Jerusalem, Jerusalem, Israel.
authors.forename: Amit
authors.initials: A
authors.lastname: Berson
authors.forename: Hermona
authors.initials: H
authors.lastname: Soreq
keywords: Acetylcholinesterase; Alzheimer’s disease; apoptosis; beta-amyloid; butyrylcholinesterase
references.citation: Brain. 2008 Jan;131(Pt 1):109-19
references.pmid: 18056160
references.citation: Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8628-33
references.pmid: 16731619
references.citation: Cancer Res. 2004 Apr 15;64(8):2652-5
references.pmid: 15087373
references.citation: Immunity. 2009 Dec 18;31(6):965-73
references.pmid: 20005135
references.citation: J Neural Transm (Vienna). 2009 Nov;116(11):1435-42
references.pmid: 19533292
references.citation: Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12
references.pmid: 17245412
references.citation: Curr Alzheimer Res. 2009 Apr;6(2):86-96
references.pmid: 19355843
references.citation: J Biol Chem. 2009 Jun 19;284(25):17170-17179
references.pmid: 19383604
references.citation: Brain Res Mol Brain Res. 2004 Aug 23;127(1-2):128-35
references.pmid: 15306129
references.citation: Neurobiol Dis. 2004 Jun;16(1):59-67
references.pmid: 15207262
references.citation: Neurodegener Dis. 2010;7(1-3):60-3
references.pmid: 20173328
references.citation: PLoS One. 2008 Sep 01;3(9):e3108
references.pmid: 18769671
references.citation: Trends Neurosci. 2006 Apr;29(4):216-24
references.pmid: 16516310
references.citation: Nature. 2008 Feb 7;451(7179):720-4
references.pmid: 18256671
references.citation: Cell. 2009 Mar 20;136(6):1001-4
references.pmid: 19303844
references.citation: Chem Biol Interact. 1993 Jun;87(1-3):209-16
references.pmid: 8343977
references.citation: Hum Mol Genet. 1998 May;7(5):937-9
references.pmid: 9536100
references.citation: Nat Rev Neurosci. 2007 Sep;8(9):663-72
references.pmid: 17684513
references.citation: Curr Alzheimer Res. 2005 Jul;2(3):291-300
references.pmid: 15974894
references.citation: Trends Biochem Sci. 2004 Feb;29(2):95-102
references.pmid: 15102436
references.citation: Nat Med. 2008 Aug;14(8):837-42
references.pmid: 18568035
references.citation: Neurogenetics. 2004 Dec;5(4):223-7
references.pmid: 15480879
references.citation: Curr Opin Neurobiol. 2007 Feb;17(1):43-52
references.pmid: 17275284
references.citation: Nature. 2006 Mar 16;440(7082):352-7
references.pmid: 16541076
references.citation: J Neurochem. 2004 Mar;88(5):1102-13
references.pmid: 15009666
references.citation: J Biol Chem. 2004 Jul 9;279(28):29740-51
references.pmid: 15123727
references.citation: Hum Genet. 1999 Feb;104(2):158-63
references.pmid: 10190327
references.citation: Nat Med. 1996 Dec;2(12):1382-5
references.pmid: 8946841
references.citation: EMBO J. 2004 Nov 10;23(22):4394-405
references.pmid: 15526038
references.citation: Nat Rev Neurosci. 2001 Apr;2(4):294-302
references.pmid: 11283752
references.citation: Chem Biol Interact. 2010 Sep 6;187(1-3):64-71
references.pmid: 20060816
references.citation: Neuron. 1996 Apr;16(4):881-91
references.pmid: 8608006
references.citation: Neurosignals. 2002 May-Jun;11(3):130-43
references.pmid: 12138250
references.citation: Blood. 2007 May 15;109(10):4383-91
references.pmid: 17272501
references.citation: DNA Cell Biol. 2005 Sep;24(9):563-73
references.pmid: 16153157
references.citation: J Neurosci. 2004 Nov 3;24(44):9993-10002
references.pmid: 15525785
references.citation: Nature. 1998 May 28;393(6683):373-7
references.pmid: 9620801
references.citation: Science. 2002 Jan 18;295(5554):508-12
references.pmid: 11799248
references.citation: Neurobiol Aging. 2003 Oct;24(6):777-87
references.pmid: 12927760
references.citation: Biochem J. 2002 Nov 1;367(Pt 3):687-95
references.pmid: 12153398
references.citation: Neurodegener Dis. 2008;5(3-4):232-6
references.pmid: 18322399
references.citation: J Neurol Neurosurg Psychiatry. 2005 May;76(5):640-3
references.pmid: 15834019
references.citation: Neuron. 2008 Nov 26;60(4):534-42
references.pmid: 19038212